South China Morning Post · General

Inside a plant in China producing the WHO-approved Sinovac Covid-19 vaccine | South China Morning Post

Story summary

The WHO approval of Sinovac Biotech’s coronavirus vaccine for emergency use on June 1, 2021, will help ease the global vaccine shortage. Sinovac Biotech has already distributed more than 600 million doses of its CoronaVac vaccine to nearly 40 countries, as of May 31, 2021. It uses an inactivated virus to trigger a p…

Read at South China Morning Post

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.